<p><strong>Gastrointestinal Stromal Tumor (GIST)</strong>: Sunitinib is indicated for the treatment of gastrointestinal stromal tumor after disease progression on or intolerance to imatinib mesylate.<br />
<br />
<strong>Advanced Renal Cell Carcinoma (RCC)</strong>: Sunitinib is indicated for the treatment of advanced renal cell&nbsp;carcinoma.<br />
<br />
<strong>Advanced Pancreatic Neuroendocrine Tumors (pNET)</strong>: Sunitinib is indicated for the treatment of progressive, well-differentiated&nbsp;pancreatic neuroendocrine tumors&nbsp;in patients with&nbsp;unresectable&nbsp;locally advanced or metastatic disease.</p>